Impax Reports Solid Second Quarter 2017 Results with Total Revenues Increasing 17% to $202 Million


HAYWARD, Calif., Aug. 9, 2017 /PRNewswire/  Impax Laboratories, Inc. (NASDAQ: IPXL), today announced second quarter 2017 financial results. Total revenues in the second quarter 2017 were $202.1 million, an increase of 17.1%, compared to $172.6 million in the prior year period, driven by a 24.0% increase in generic product sales. GAAP net loss was $20.4 million or a loss of $0.28 per [ ] The post Impax Reports Solid Second Quarter 2017 Results with Total Revenues Increasing 17% to $202 Million appeared first on STL News.
http://bit.ly/2uoV9QU

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Create a website or blog at WordPress.com

Up ↑

%d bloggers like this: